SHANK2 and esophageal squamous cell carcinoma: ESCC showed the amplification of a region starting with CCND1 and ending around SHANK2 in 11q13.3, and another significant amplification in ESCC was from PIK3CA to SOX2 in 3q26.31, coupled with deletion of CDKN2A in 9p21.3.